Targeting Cyclin-Dependent Kinase 9 by a Novel Inhibitor Enhances Radiosensitization and Identifies Axl as a Novel Downstream Target in Esophageal Adenocarcinoma

Oncotarget - United States
doi 10.18632/oncotarget.27095
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

Impact Journals, LLC

Related search

Targeting Regulation of Cyclin Dependent Kinase 9 as a Novel Therapeutic Strategy in Synovial Sarcoma

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2019English

A Novel Machine Learning Approach Uncovers New and Distinctive Inhibitors for Cyclin-Dependent Kinase 9

2020English

A Novel Binding Pocket of Cyclin-Dependent Kinase 2

Proteins: Structure, Function and Genetics
BiochemistryStructural BiologyMolecular Biology
2009English

Therapeutic Activity of DCC-2036, a Novel Tyrosine Kinase Inhibitor, Against Triple-Negative Breast Cancer Patient-Derived Xenografts by Targeting AXL/MET

International Journal of Cancer
Cancer ResearchOncology
2018English

P12DOC-1 Is a Novel Cyclin-Dependent Kinase 2-Associated Protein

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Integrated Genomic Analysis Identifies the Mitotic Checkpoint Kinase WEE1 as a Novel Therapeutic Target in Medulloblastoma

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma

International Journal of Oncology
Cancer ResearchOncology
2015English

Preliminary Crysallization of a Cyclin-Dependent Kinase Inhibitor: P18

Acta Crystallographica Section A Foundations of Crystallography
1996English

Cyclin-Dependent Kinase Activity Is Required for Progesterone Receptor Function: Novel Role for Cyclin a/Cdk2 as a Progesterone Receptor Coactivator

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy